Conference Coverage
Latest News
Jun 24, 2026 | News
FDA Approves Sacituzumab Govitecan for First-Line Treatment of Advanced Triple-Negative Breast Cancer
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
Jun 24, 2026
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D-Mutated Advanced NSCLC
Jun 24, 2026
Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia
Jun 24, 2026
FDA Approves Palbociclib-Based Maintenance Regimen for HR-Positive, HER2-Positive Metastatic Breast Cancer
Jun 24, 2026
Advertisement
Shorts
0:44
Preparing Oncology Pharmacists for Increasingly Complex Cancer Care
16 hours ago
by
Chris Elder, PharmD, BCOP(+1 more)
1:14
McKesson ideaShare Brings Advocacy and Pharmacy Together
4 days ago
by
Sandie Kueker, RPh(+1 more)
0:31
Independent Pharmacy Furthers Health Outcomes for All | McKesson ideaShare 2026
5 days ago
by
Niki Shah, MHSA, MBA, CCHW(+2 more)
0:52
What to Know as McKesson ideaShare Comes to Denver
6 days ago
by
Luke Halpern, Associate Editor
1:51
How Hantavirus Spreads and How to Protect Patients
6 days ago
by
Saro Arakelians, PharmD(+1 more)
1:32
Once-Weekly Insulin Icodec Approved for Type 2 Diabetes
8 days ago
by
Saro Arakelians, PharmD(+1 more)
0:42
Can Pembrolizumab Enhance Olaparib Maintenance Therapy in Metastatic Pancreatic Cancer? Insights From SWOG S2001
9 days ago
by
Vincent Chung, MD(+1 more)
1:58
Expert Cardiologists Give Advice to Pharmacists to Improve Care Tomorrow
13 days ago
by
Luke Halpern, Associate Editor(+3 more)
0:55
Anti-Amyloid Therapies Create Hope and Complexities in Alzheimer Disease Treatment
16 days ago
by
Josean Gonzalez, PharmD, BCPP(+1 more)
0:33
ePROs Help Reduce Hospitalizations and Improve Cancer Care
21 days ago
by
Debra Patt, MD, PhD, MBA(+1 more)
Podcasts
Videos
Continuing Education
Advertisement
All News
Advertisement
Pharmacists should be up-to-date on current outbreak status, US risk level, and how to recognize warning signs and counsel concerned patients as confirmed Ebola cases caused by Bundibugyo ebolavirus continue to rise across the Democratic Republic of the Congo (DRC) and Uganda.
The new indication is for those aged 12 years and older with unresectable or metastatic SS who received prior chemotherapy and are positive for certain genetic subtypes.
On GLP-1s like semaglutide or tirzepatide, weight loss can mean muscle loss; encourage patients to use protein and resistance training to stay strong.
Understanding this rapidly evolving therapeutic landscape will be essential as obesity pharmacotherapy continues to transform diabetes and cardiometabolic care.
Incorporate important health screenings and lifestyle prevention tips in MTM consults.
From AI-driven dispensing to grassroots advocacy wins, here are the key insights Pharmacy Times gathered at McKesson ideaShare 2026 in Denver.
Specialty dispensing and infusion services offer real opportunity—but the path requires careful planning, sequencing, and the right resources.
Single-cell findings presented at EHA 2026 identify B cells as potential drivers of immune dysregulation in acquired hemophilia A.
Ammoxetine is a novel SNRI derived from duloxetine, exhibiting a 3- to 10-fold greater potency.
Leonard Egede explains why PHQ-9 screening belongs in every cardio-kidney-metabolic (CKM) syndrome risk assessment—and how community pharmacists can reach patients the formal system misses.
Advertisement
The multiple myeloma (MM) approval was based on phase 3 IRAKLIA data demonstrating noninferior efficacy and reduced infusion-related reactions compared with intravenous administration.
Pharmacists cut through probiotic hype by matching strains and doses to evidence, checking shelf-life potency, and navigating confusing regulations.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
Human connection is often the first casualty of rising prescription counts and constant interruptions.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
Three finalist pharmacies shared the mindsets, tools, and community-rooted strategies driving their operational success and patient-centered care.
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
Oncology pharmacists step into precision care—tracking mRNA vaccines, frailty-guided supportive therapy, NGS actionability, and new thoracic targets.
Two pharmacy owners share real-world strategies for integrating artificial intelligence (AI) and automation to boost efficiency, expand clinical capacity, and elevate patient care.
New GI cancer data highlight emerging targeted therapies, ctDNA-guided surveillance, and pharmacist-led workflows to boost outcomes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
ADA 2026: Diabetes Technology Innovations Expand Beyond Traditional CGM Use
4
Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia
5